Search research articles
Contact Us
Filters
Showing results (1-10 of 281) with videos related to
Page
of 29
Sort By:
Cell Cycle (Georgetown, Tex.)
|
September 14, 2006
Proliferation: the most prominent predictor of clinical outcome in breast cancer
Christine Desmedt, Christos Sotiriou
Nature Reviews. Clinical Oncology
|
July 25, 2013
Luminal breast cancer: from biology to treatment
Michail Ignatiadis, Christos Sotiriou
Nature Reviews. Cancer
|
June 23, 2007
Taking gene-expression profiling to the clinic: when will molecular signatures become relevant to patient care?
Christos Sotiriou, Martine J Piccart
Breast Cancer Research : BCR
|
July 9, 2002
Defining the galaxy of gene expression in breast cancer
Edison T Liu, Christos Sotiriou
EMBO Molecular Medicine
|
January 1, 2010
Decoding the evolution of a breast cancer genome
Philippe L Bedard, Christos Sotiriou
Current Opinion in Oncology
|
August 14, 2010
Circulating tumor cells and emerging blood biomarkers in breast cancer
Carmen Criscitiello, Christos Sotiriou, Michail Ignatiadis
Critical Reviews in Oncology/Hematology
|
November 8, 2006
The use of gene-expression profiling to better understand the clinical heterogeneity of estrogen receptor positive breast cancers and tamoxifen response
Sherene Loi, Martine Piccart, Christos Sotiriou
Bulletin Du Cancer
|
April 9, 2008
[Has the time arrived for gene expression use at the bedside?]
Véronique D'Hondt, Martine Piccart, Christos Sotiriou
Discover Oncology
|
September 29, 2025
Case report: metachronous male metastatic breast and colon cancer in a BRCA2 mutation carrier
Emiliana Larionesi, Oana-Nicoleta Pilet, Christos Sotiriou
Critical Reviews in Oncology/Hematology
|
February 9, 2010
Genomic Grade Index: An important tool for assessing breast cancer tumor grade and prognosis
Otto Metzger Filho, Michail Ignatiadis, Christos Sotiriou
Page
of 29
Search research articles
Search
Showing results (1-10 of 281) with videos related to
Sort By:
Page
of 29
Cell Cycle (Georgetown, Tex.)
|
September 14, 2006
Proliferation: the most prominent predictor of clinical outcome in breast cancer
Christine Desmedt, Christos Sotiriou
Nature Reviews. Clinical Oncology
|
July 25, 2013
Luminal breast cancer: from biology to treatment
Michail Ignatiadis, Christos Sotiriou
Nature Reviews. Cancer
|
June 23, 2007
Taking gene-expression profiling to the clinic: when will molecular signatures become relevant to patient care?
Christos Sotiriou, Martine J Piccart
Breast Cancer Research : BCR
|
July 9, 2002
Defining the galaxy of gene expression in breast cancer
Edison T Liu, Christos Sotiriou
EMBO Molecular Medicine
|
January 1, 2010
Decoding the evolution of a breast cancer genome
Philippe L Bedard, Christos Sotiriou
Current Opinion in Oncology
|
August 14, 2010
Circulating tumor cells and emerging blood biomarkers in breast cancer
Carmen Criscitiello, Christos Sotiriou, Michail Ignatiadis
Critical Reviews in Oncology/Hematology
|
November 8, 2006
The use of gene-expression profiling to better understand the clinical heterogeneity of estrogen receptor positive breast cancers and tamoxifen response
Sherene Loi, Martine Piccart, Christos Sotiriou
Bulletin Du Cancer
|
April 9, 2008
[Has the time arrived for gene expression use at the bedside?]
Véronique D'Hondt, Martine Piccart, Christos Sotiriou
Discover Oncology
|
September 29, 2025
Case report: metachronous male metastatic breast and colon cancer in a BRCA2 mutation carrier
Emiliana Larionesi, Oana-Nicoleta Pilet, Christos Sotiriou
Critical Reviews in Oncology/Hematology
|
February 9, 2010
Genomic Grade Index: An important tool for assessing breast cancer tumor grade and prognosis
Otto Metzger Filho, Michail Ignatiadis, Christos Sotiriou
Page
of 29